Real-world safety profile of the 9-valent human papillomavirus vaccine: A study in Zhejiang, China from 2019 to 2021

The safety profile of the 9-valent human papillomavirus vaccine (9vHPV) was evaluated based on the reporting rate of adverse events following immunization (AEFI) obtained from the passive surveillance data in Zhejiang. The 9vHPV AEFI reports in Zhejiang were collected and reviewed from the National...

Full description

Saved in:

Bibliographic Details
Main Authors:	Fuxing Chen (Author), Xuejiao Pan (Author), Hui Liang (Author), Lingzhi Shen (Author), Ying Wang (Author), Yaping Chen (Author), Huakun Lv (Author), Yu Hu (Author)
Format:	Book
Published:	Taylor & Francis Group, 2022-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Surveillance of adverse events following immunization of 13-valent pneumococcal conjugate vaccine among infants, in Zhejiang province, China
by: Yu Hu, et al.
Published: (2022)

Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine using the national adverse event following immunization surveillance system from Zhejiang province, 2018-2020
by: Yu Hu, et al.
Published: (2021)

Analysis of adverse events following immunization in Zhejiang, China, 2019: a retrospective cross-sectional study based on the passive surveillance system
by: Xuejiao Pan, et al.
Published: (2021)

Surveillance on the adverse events following immunization with the pentavalent vaccine in Zhejiang, China
by: Xuejiao Pan, et al.
Published: (2022)

Cost-effectiveness analysis of introducing rotavirus vaccine into immunization program in Zhejiang province, China: A decision tree-Markov model study
by: Huakun Lv, et al.
Published: (2023)

Barriers to healthcare workers reporting adverse events following immunization in Zhejiang province, China
by: Huakun Lv, et al.
Published: (2022)

The association between the density of vaccination workers and immunization coverage in Zhejiang province, East China
by: Yu Hu, et al.
Published: (2021)

Evaluating the vaccination coverage: validity of household-hold vaccination booklet and caregiver's recall
by: Yu Hu, et al.
Published: (2021)

Post-marketing surveillance for the safety of the 9-valent human papillomavirus vaccine: a retrospective real-world study in China
by: Ruogu Meng, et al.
Published: (2023)

Analysis of the adverse events following immunization with inactivated quadrivalent influenza vaccine from 2018 to 2020 in Zhejiang province, with a comparison to trivalent influenza vaccine
by: Huakun Lv, et al.
Published: (2021)

Can vaccination coverage be improved through reducing the missed opportunities for immunization? Results from the evaluation in Zhejiang province, east China
by: Yaping Chen, et al.
Published: (2021)

The trends of socioeconomic inequities in full vaccination coverage among children aged 12-23 months from 2000 to 2017: evidence for mitigating disparities in vaccination service in Zhejiang province
by: Yu Hu, et al.
Published: (2021)

Age-appropriate vaccination coverage and its determinants for the polio containing vaccine 1-3 and measles-containing vaccine doses in Zhejiang province, China: A community-based cross-sectional study
by: Yu Hu, et al.
Published: (2020)

Extended surveillance to assess safety of 9-valent human papillomavirus vaccine
by: Maria E. Sundaram, et al.
Published: (2022)

Preference and willingness to pay of female college students for human papillomavirus vaccination in Zhejiang Province, China: A discrete choice experiment
by: Ying Wang, et al.
Published: (2021)

9-Valent human papillomavirus vaccine: a review of the clinical development program
by: Alain Luxembourg, et al.
Published: (2017)

Off-Label 9-Valent Human Papillomavirus Vaccination for Actinic Keratosis: A Case Series
by: Emily Wenande, et al.
Published: (2021)

Immunogenicity and safety of quadrivalent and 9-valent human papillomavirus vaccines in Indian clinical trial participants
by: Suzanne M. Garland, et al.
Published: (2022)

Post-marketing safety surveillance study of a 9-valent human papillomavirus vaccine: Comment
by: Hinpetch Daungsupawong, et al.
Published: (2024)

Systemic 9-valent human papillomavirus vaccine for recalcitrant common cutaneous warts in preparation for renal transplant
by: W. Austin Wyant, MSc, et al.
Published: (2022)

Myasthenia gravis after the third dose of human papillomavirus 9-valent vaccine: A case report
by: Yuan Ding, et al.
Published: (2023)

Health Impact and Cost-Effectiveness of Implementing Gender-Neutral Vaccination With the 9-Valent Human Papillomavirus Vaccine in Belgium
by: Steven Simoens, et al.
Published: (2021)

Measuring childhood vaccination acceptance of mother in Zhejiang province, East China
by: Yu Hu, et al.
Published: (2019)

Expanded strain coverage for a highly successful public health tool: Prophylactic 9-valent human papillomavirus vaccine
by: Zhigang Zhang, et al.
Published: (2017)

Immunogenicity of a trivalent influenza vaccine and persistence of induced immunity in adults aged ≥60 years in Taizhou City, Zhejiang Province, China, during the 2018-2019 season
by: Yuting Liao, et al.
Published: (2022)

Spotlight on the 9-valent HPV vaccine
by: Lopalco PL
Published: (2016)

Routine vaccination coverage of children aged 1-7 years in Zhejiang province, China
by: Yu Hu, et al.
Published: (2018)

Surveillance analysis of adverse events following immunization with the bivalent human papillomavirus vaccine and recombinant human papillomavirus 9-valent vaccine in Hebei province from 2018 to 2022
by: Jinghui WANG, et al.
Published: (2024)

Systemic and intratumoral 9-valent human papillomavirus vaccine treatment for squamous cell carcinoma in situ in a renal transplant recipient
by: Anna J. Nichols, MD, PhD, et al.
Published: (2020)

Reliability and validity of a survey to identify vaccine hesitancy among parents in Changxing county, Zhejiang province
by: Yu Hu, et al.
Published: (2019)

Epidemiology of foodborne diseases caused by Salmonella in Zhejiang Province, China, between 2010 and 2021
by: Yue He, et al.
Published: (2023)

Post-marketing safety surveillance study of a 9-valent human papillomavirus vaccine in individuals aged 16-26 years in Chongqing, China
by: Yuan-yuan Zhang, et al.
Published: (2023)

Safety profile of the 9-valent human papillomavirus vaccine: assessment in prior quadrivalent HPV vaccine recipients and in men 16 to 26 years of age
by: E. D. Moreira, et al.
Published: (2018)

Non-typhoidal Salmonella infections among children in a tertiary hospital in Ningbo, Zhejiang, China, 2012-2019.
by: Yefang Ke, et al.
Published: (2020)

Initiation and completion rates of inactivated hepatitis A vaccination among children born between 2005 and 2014 in Zhejiang province, east China
by: Yu Hu, et al.
Published: (2018)

Measles vaccination coverage, determinants of delayed vaccination and reasons for non-vaccination among children aged 24-35 months in Zhejiang province, China
by: Yu Hu, et al.
Published: (2018)

Post-marketing study design to evaluate the effectiveness of the 9-valent and 4-valent HPV vaccines on serious HPV-related cervical disease in China
by: Yu Yang, et al.
Published: (2024)

Immunogenicity and safety of a nine-valent human papillomavirus vaccine in Vietnamese males and females (9 to 26 years of age): an open-label, phase 3 trial
by: Vu Dinh Thiem, et al.
Published: (2021)

Changes in real-world dispensing of ADHD stimulants in youth from 2019 to 2021 in California
by: Anika Patel, et al.
Published: (2024)

Cetuximab Can Be an Effective and Low-Toxicity Maintenance Treatment Drug in Patients With Metastatic Colorectal Cancer: A Real-World Study of Zhejiang Cancer Hospital
by: Meiqin Yuan, et al.
Published: (2021)